KEGG   PATHWAY: mmf05213
Entry
mmf05213                    Pathway                                
Name
Endometrial cancer - Molossus molossus (Pallas's mastiff bat)
Description
Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.
Class
Human Diseases; Cancer: specific types
Pathway map
mmf05213  Endometrial cancer
mmf05213

Disease
H00026  Endometrial cancer
Organism
Molossus molossus (Pallas's mastiff bat) [GN:mmf]
Gene
118615159  CTNNA1; catenin alpha-1 [KO:K05691]
118615385  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
118615490  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
118616287  APC2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
118616460  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
118616724  SOS2; son of sevenless homolog 2 isoform X1 [KO:K03099]
118616774  ILK; integrin-linked protein kinase isoform X1 [KO:K06272] [EC:2.7.11.1]
118617106  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
118617870  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
118619570  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
118619617  [KO:K04456] [EC:2.7.11.1]
118620077  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
118621843  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
118621850  BAK1; bcl-2 homologous antagonist/killer [KO:K14021]
118621858  FOXO3; forkhead box protein O3 [KO:K09408]
118624619  KRAS; GTPase KRas isoform X1 [KO:K07827]
118626427  CASP9; caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
118626685  [KO:K02649]
118626944  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
118627118  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
118627554  DDB2; DNA damage-binding protein 2 [KO:K10140]
118627989  BAD; bcl2-associated agonist of cell death [KO:K02158]
118628257  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
118628434  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
118630299  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
118630561  [KO:K05691]
118630569  TCF7L1; transcription factor 7-like 1 [KO:K04490]
118630851  CTNNA2; catenin alpha-2 [KO:K05691]
118630966  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
118631560  MYC; myc proto-oncogene protein [KO:K04377]
118632022  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
118632133  CTNNA3; catenin alpha-3 [KO:K05691]
118632142  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X1 [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
118632900  CTNNB1; catenin beta-1 [KO:K02105]
118632927  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
118633081  MLH1; DNA mismatch repair protein Mlh1 isoform X1 [KO:K08734]
118633343  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
118633806  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
118633888  ERBB2; receptor tyrosine-protein kinase erbB-2 [KO:K05083] [EC:2.7.10.1]
118634494  EGF; pro-epidermal growth factor isoform X1 [KO:K04357]
118634552  TP53; cellular tumor antigen p53 isoform X1 [KO:K04451]
118634920  AXIN2; axin-2 [KO:K04385]
118635666  ARAF; serine/threonine-protein kinase A-Raf isoform X1 [KO:K08845] [EC:2.7.11.1]
118636653  ELK1; LOW QUALITY PROTEIN: ETS domain-containing protein Elk-1 [KO:K04375]
118637343  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
118637822  NRAS; GTPase NRas [KO:K07828]
118638405  AKT2; RAC-beta serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
118638701  BAX; apoptosis regulator BAX [KO:K02159]
118639271  CDH1; cadherin-1 [KO:K05689]
118640210  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
118640620  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
118641379  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
118641544  AXIN1; axin-1 isoform X1 [KO:K02157]
118642307  MAPK3; mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:2.7.11.24]
118642579  POLK; DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
118642806  PDPK1; 3-phosphoinositide-dependent protein kinase 1 isoform X1 [KO:K06276] [EC:2.7.11.1]
118642883  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
118643162  HRAS; GTPase HRas isoform X1 [KO:K02833]
118643440  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
118643629  TCF7; transcription factor 7 isoform X1 [KO:K02620]
Compound
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Related
pathway
mmf04010  MAPK signaling pathway
mmf04012  ErbB signaling pathway
mmf04060  Cytokine-cytokine receptor interaction
mmf04110  Cell cycle
mmf04115  p53 signaling pathway
mmf04151  PI3K-Akt signaling pathway
mmf04310  Wnt signaling pathway
mmf04520  Adherens junction
KO pathway
ko05213   

DBGET integrated database retrieval system